Erasmus MC Incubator, YES!Delft, unlock_and Rotterdam Square have launched the MedTech Accelerator Program to connect tech startups with the clinical world. This program fosters connections between emerging medical technology companies and hospital stakeholders, ensuring that new technologies are developed to benefit healthcare providers and patients.
Participants of the program are Corbotics, Access2Bone, Sensible Healthcare Systems, Sonosilicon, Acoustic Insight, SoundCell (Graphiti), Lyla and SATA Medical.
Part of the kick-off was a visit to the new Erasmus MC Skillslab & Simulation Center and the Experimental Medical Instrumentation facility and Innovation Lab. A workshop from IDE Group on Human Factors Engineering and an inspiring talk from BeVinced on the Basics of MDR (Medical Device Regulation).
For more information, visit MedTech Accelerator | YES!Delft.
About YES!Delft
With a strong focus on deep tech, YES!Delft supports startups with high-impact solutions in AI, cleantech, and MedTech, fostering the development of next-generation innovations. By connecting our unique startup programs & services with our regional ecosystem of experts, mentors, partners, and investors, we help build tomorrow’s leading tech firms.
About Rotterdam Square
Rotterdam Square is the campus organization of the Erasmus MC Campus, dedicated to connecting the Life Sciences & Health ecosystem in the Rotterdam region. The organization believes that synergy drives success and actively uses the power of networking to bring the community together. Its mission is to connect experts in healthcare, science, and technology – from academia and industry – to accelerate health and tech innovations and shape the future of healthcare.
About unlock_
unlock_ is part of PLNT, Leidens’ University incubator. It offers LSH-companies support over all stages of the start-up cycle from ideation, activation and inspiration through validation (the three-month Venture Academy), the unlock_ Incubation Program: a full-year entrepreneurship program to support life science and biotechnology start-ups in this early phase to become “economically active.” In other words: raise money, spend money strategically and build healthy teams.
